Securing the AI Development Lifecycle

AI pipelines aggregating patient genomic data and electronic consent records represent exactly the kind of high-value, under-secured infrastructure that sophisticated attackers actively target.

ConsentVault deploys AI tools to manage structured clinical data, genomic ingestion pipelines, and patient eConsent workflows across research and community oncology settings. When the organization evaluated how to protect this infrastructure, the answer was not a better detection tool. It was a different architecture entirely.

In clinical AI environments, detecting a breach of non-anonymous biological data or a corrupted consent record after the fact is a failure. Patient genomic information cannot be rotated like a compromised password or reissued like a stolen credential. A consent record that an adversary has accessed or altered cannot be un-accessed. The standard reactive posture of detect, alert, respond has no meaningful remediation step when the data involved is both irreplaceable and legally binding.

Xiid's Terniion platform gave ConsentVault a fundamentally different foundation: not a detection layer, but a deterministic security architecture that removes infrastructure from the attack surface before exposure is possible, eliminates credentials from the wire, and enforces process-level isolation across every data flow without degrading the throughput that AI training workloads require.

Industry Challenge: The Unique Threat Model of Clinical AI

Across oncology research, community clinical practice, and pharmaceutical-sponsored trial operations, AI-enabled healthcare organizations face a threat model that is structurally different from general enterprise security:

• Healthcare is the most targeted sector. The industry reported more cyberthreats in 2024 than any other sector. Attackers prioritize healthcare because the combination of sensitive data, compliance pressure, and operational urgency creates both high-value targets and favorable conditions for coercion.

• Genomic data cannot be remediated after compromise. Unlike passwords, tokens, or even financial records, patient genomic information is permanent and uniquely identifying. A single exfiltration event creates a permanent exposure. There is no credential rotation that addresses it.

• AI ingestion pipelines are under-secured by design. The same connectivity that makes AI systems powerful—continuous data ingestion from distributed sources, access to data lakes and document stores, integration with external clinical systems—creates attack surface that conventional perimeter tools were not built to address. Pipelines that ingest data at AI scale cannot be protected by approaches that require interrupting the data flow.

• Model poisoning is a clinical safety risk. In clinical AI systems, data manipulation is both a security incident and a patient safety event. An adversary who can alter the data feeding a diagnostic or treatment AI doesn't just steal information. They corrupt the decisions that follow from it.

• Compliance is non-negotiable, but it doesn't equal security. HIPAA and EU GDPR establish minimum standards for data handling. They do not require and cannot substitute for an architecture that prevents unauthorized access from occurring in the first place. Attestation of compliance after a breach does not undo the breach.

• eConsent records carry legal weight that detection cannot protect. A consent record that has been accessed or altered by an unauthorized party creates liability that survives any subsequent remediation effort. The integrity of the consent process must be guaranteed before exposure occurs, not investigated after.

In Practice: A Government-Focused Managed Services Provider

ConsentVault's platform serves oncology and clinical practices that need to capture, track, and operationalize patient consent for the ethical use of PHI and diagnostic data across treatment, research, and AI-powered analytics. The organization operates at the intersection of several distinct high-sensitivity data types: structured clinical records, patient genomic information, and legally binding eConsent documentation all flowing through AI pipelines that must remain operational without interruption.

When ConsentVault evaluated its security posture, the threat model it confronted was specific. Terniion does not add another detection layer to address it. It removes the attack surface that detection depends on finding.

• Threat 1: Exfiltration from AI ingestion pipelines. Genomic data ingested for AI training workloads passes through pipelines that must handle high throughput. Approaches that interrupt data flow to inspect it create operational constraints that are incompatible with AI training at scale.

• Threat 2: Data manipulation and model poisoning. An adversary with access to a clinical AI training pipeline doesn't need to exfiltrate data to cause harm. They can alter data in place corrupts the downstream model and every decision it produces. ConsentVault ingests third-party data it does not control, which means a compromised upstream source is a realistic attack vector, not a theoretical one.

• Threat 3: eConsent record integrity. A consent record that has been accessed or altered by an unauthorized party creates liability that survives any subsequent remediation effort. The integrity of the consent process must be guaranteed before exposure occurs, not investigated after.

• Threat 4: Inference endpoint exposure. Deployed AI inference endpoints are a distinct and often overlooked attack surface. Unlike training pipelines, inference endpoints must respond to queries in real time which traditionally means they must be reachable. In clinical settings, an exposed inference endpoint is both a data exfiltration vector and a target for adversarial inputs designed to manipulate model outputs.

The Xiid Solution: Eliminate Exposure Before It Becomes a Breach

Terniion addresses all four through two architectural capabilities.

1. Make Network and AI Infrastructure Non-Addressable

The most direct way to prevent a breach of AI data infrastructure is to make that infrastructure unreachable to attackers in the first place. Terniion keeps ConsentVault's AI data ingestion pipelines, data lakes, inference endpoints, and document stores completely non-addressable from the internet.

There are no open inbound ports. There are no exposed services for attackers to find, scan, or probe. The infrastructure is not hidden by a firewall or obscured by a VPN. It is architecturally absent from the attack surface. If an attacker cannot reach a system, they cannot exfiltrate data from it, manipulate its inputs, or poison the models it trains. This applies equally to inference endpoints: they remain fully accessible to authorized processes while remaining invisible to everything else, which resolves the availability-versus-security tradeoff that makes inference endpoints a persistent risk in clinical AI deployments.

For pharmaceutical sponsors, community oncology practices, and payers evaluating ConsentVault for real-world evidence generation and clinical trial operations, this is the security posture they require: not a promise that breaches will be detected quickly, but a guarantee that the infrastructure cannot be reached.

2. Enforce Authorized-Only Data Flow

Even inside a secured perimeter, lateral movement remains a persistent risk. An adversary who compromises one system can traverse shared network layers to reach others. In clinical AI environments, where data flows connect consent management, genomic ingestion, training pipelines, and inference endpoints, the potential blast radius of a single compromise is significant.

Terniion enforces process-to-process isolation structurally. Every data flow operates through its own dedicated, outbound-only, triple-encrypted connection. There is no shared network layer. Lateral movement between processes or environments is architecturally impossible. It’s not restricted by policy but eliminated by design.

Specifically, if any source of ingested data is compromised by malware or full remote compromise, the data lake is still protected from data poisoning. For ConsentVault's use case, they are ingesting third-party data that they do not control. Terniion provides the necessary layer of security within their partners' environment to ensure the continued integrity of their data pipeline.

Patient data and AI workloads move only through these isolated tunnels. Clinicians and patients experience no change in how they use the system. The security boundary is invisible to the workflow and absolute to an adversary.

The result is a security architecture that Patricia Goede, ConsentVault's chief data strategy officer, describes in direct terms: "Terniion gives us the confidence to let our AI do the hard work on highly sensitive clinical, diagnostic, and treatment data without ever compromising patient privacy or intellectual property security. By wrapping the entire ConsentVault platform in Xiid's encrypted SealedTunnel technology, our inference endpoints, training pipelines, and data repositories are fully isolated from the public internet, which is precisely the security posture pharmaceutical sponsors, community oncology practices, and payers expect when entrusting us with real-world evidence generation and clinical trial operations."

Under active HIPAA and EU GDPR compliance obligations, ConsentVault operates with the confidence that its security posture is architectural, not policy-dependent. Compliance attestation documents what controls are in place. Terniion ensures those controls cannot be bypassed.

Proven Reliability

Terniion carries an unconditional Authority to Operate from the U.S. Department of Defense. This designation has not been awarded to any other cybersecurity vendor. The U.S. Air Force Research Laboratory conducted independent penetration testing in 2024 and declared the infrastructure effectively unreachable to standard attack methodologies.

Terniion is currently protecting workloads for the Defense Health Agency, CI/CD pipelines for defense contractors, and sensitive data flows across federal agencies, as well as enterprise AI tools and EV charging infrastructure. The platform scales from single endpoints to enterprise environments with tens of thousands of managed assets, with SealedTunnels deployable in under 90 seconds and manageable from a single control plane.

Conclusion

Clinical AI operates on data that cannot be remediated after compromise. The organizations that recognize this and build their security architecture around preventing exposure rather than detecting it are the ones that can credibly make the promises their clients, partners, and regulators require.

ConsentVault chose Terniion because the alternative of a detection-dependent posture was structurally incompatible with the threat model it faced. Genomic data doesn't have a recovery path. Consent records carry legal liability that survives any incident response. And the AI pipelines aggregating both were exactly the kind of infrastructure that sophisticated adversaries target.

Terniion removes that infrastructure from the attack surface entirely. It enforces process-level isolation that makes lateral movement architecturally impossible. And it does all of this without changing how clinicians, researchers, or patients interact with the platform.